Safety and Efficacy of MILEP Versus Standard EEP
The MILES Trial: Prospective Randomized Trial of Safety and Efficacy of Minimally-invasive Versus Standard Laser Enucleation of the Prostate
Sechenov University
340 participants
Mar 14, 2024
INTERVENTIONAL
Conditions
Summary
Endoscopic enucleation of the prostate (EEP) is a standard treatment for benign prostatic hyperplasia (BPH), with modifications such as MiLEP that utilizes smaller instruments. The reduced resectoscope diameter in MiLEP may help decrease rates of stress urinary incontinence (SUI) and urethral strictures. Objective: to compare the efficacy and safety of MiLEP and standard EEP with a thulium fiber laser (TFL).
Eligibility
Inclusion Criteria3
- LUTS presence, proven by:
- IPSS questionnaire (Score \>20);
- OR uroflowmetry result (Qmax \<10 ml/s);
Exclusion Criteria6
- Prostate volume \> 120 cc
- Prostate cancer on pathology;
- Urethral strictures;
- Bladder calculi;
- Prior prostate surgery;
- Neurogenic bladder dysfunction.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Stabdard EEP will be nerformed using 26 Ch resectoscope. Enucleation will be performed using an en bloc no-touch technique with early apical release.
Minimally-invasive laser EEP will be nerformed using 22 Ch resectoscope. Enucleation will be performed using an en bloc no-touch technique with early apical release.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06839768